v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The components of the Company’s share-based compensation expense for the six months ended June 30, 2026 and 2025 are as follows:
Six Months Ended June 30,
20262025
(in thousands)
Stock options$599 $1,934 
Restricted stock units and deferred stock units3,757 3,548 
Performance stock units1,050 713 
Employee Stock Purchase Plan179 84 
Total share-based compensation expense$5,585 $6,279 
The following table summarizes the components of share-based compensation expense included within the Consolidated Statements of Comprehensive Income/(Loss) for the six months ended June 30, 2026 and 2025:

Six Months Ended June 30,
20262025
(in thousands)
Selling, general and administrative$5,540 $6,257 
Costs of services provided45 22 
Total share-based compensation expense$5,585 $6,279 
Schedule of Stock Options Outstanding
A summary of stock options outstanding under the Amended Plan and the 2012 Plan as of December 31, 2025 and changes during the six months ended June 30, 2026 are as follows:
Stock Options Outstanding
Number of SharesWeighted Average Exercise Price
(in thousands)
December 31, 20252,486 $25.99 
Granted— $— 
Exercised(72)$15.97 
Forfeited— $— 
Expired(301)$34.24 
June 30, 20262,113 $25.38 
Schedule of Assumption for Fair Value of Options Granted
The fair value of stock option awards granted during the six months ended June 30, 2025 was estimated on the date of the grant using the Black-Scholes option valuation model with the following assumptions:
Six Months Ended June 30,
20262025
Risk-free interest rateN/A4.5 %
Weighted average expected lifeN/A7.2 years
Expected volatilityN/A42.1 %
Dividend yieldN/A— %
Schedule of Other Information about Stock Options
The following table summarizes other information about the stock options outstanding at June 30, 2026:
June 30, 2026
(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value$11,308 
Weighted average remaining contractual life4.6 years
Exercisable:
Number of options1,571 
Weighted average exercise price$29.85 
Aggregate intrinsic value$4,728 
Weighted average remaining contractual life3.6 years
Schedule of Outstanding Restricted Stock Units
A summary of the outstanding RSUs and DSUs as of December 31, 2025 and changes during the six months ended June 30, 2026 is as follows:
Restricted Stock Units & Deferred Stock Units
Number of UnitsWeighted Average Grant Date Fair Value
(in thousands)
December 31, 20251,791 $12.68 
Granted490 $18.17 
Vested(498)$14.29 
Forfeited(24)$13.88 
June 30, 20261,759 $13.74 
Schedule of Outstanding Performance Stock Units
A summary of the outstanding PSUs as of December 31, 2025 and changes during the six months ended June 30, 2026 is as follows:

Performance Stock Units
Number of UnitsWeighted Average Grant Date Fair Value
(in thousands)
December 31, 2025304 $14.00 
Granted186 $21.12 
Vested(108)$16.20 
Forfeited— $— 
June 30, 2026382 $16.84 
Schedule of Options Granted Under Employee Stock Purchase Plan
The expense associated with the options granted under the ESPP during the six months ended June 30, 2026 and 2025 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

Six Months Ended June 30,
20262025
Risk-free interest rate3.5%4.2%
Weighted average expected life (years)1.01.0
Expected volatility43.9%39.3%
Dividend yield—%—%
Schedule of Supplemental Employee Retirement Plan
The following table summarizes information about the SERP during the six months ended June 30, 2026 and 2025:

Six Months Ended June 30,
 20262025
(in thousands)
SERP expense loss1
$370 $368 
Unrealized gain recorded in SERP liability account$5,323 $3,182 
1.Both the SERP match and the deferrals are included in the “Selling, general and administrative” caption in the Consolidated Statements of Comprehensive Income/(Loss).